Director Claypoole Robert E 🟡 adjusted position in 41.7K shares (1 derivative) of Bioventus Inc. (BVS) at $8.03 Transaction Date: Jan 09, 2026 | Filing ID: 000002
Hollywood Mark 🟡 adjusted position in 176.9K shares (4 derivative) of Zymeworks Inc. (ZYME) at $23.16 ($1.8M) Transaction Date: Jan 12, 2026 | Filing ID: 011885